K2 HealthVentures
Nimesh Shah is currently the Managing Director at K2 HealthVentures. Prior to this role, they served as Managing Director at Hercules Capital, Inc. and as the Chief Business Officer at Fractyl Laboratories Inc. Nimesh has also held positions such as Partner at Domain Associates. Additionally, they have served as a Board Member for companies like Miramar Labs, Twelve, Cotera, Sequent Medical, Benvenue Medical, and Zyga, many of which were acquired by various companies. Nimesh holds a BS in Biomedical Engineering from The Johns Hopkins University.
This person is not in any offices
K2 HealthVentures
K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).